Recent Headlines
Samaritan Expands Revenue Opportunities with Marketing Authorization Approval for HIV Drug Amphocil in Cyprus
Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health... - January 03, 2008 - Samaritan Pharmaceuticals
Actors Studio's Anna Strasberg Joins Samaritan Advisory Board of Directors
Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals
Three Rivers Adds Territory of Ireland to Samaritan's Existing Exclusive Licensing Agreement to Market Amphocil in Greece and Cyprus
Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals
EUSA Pharma Signs Exclusive Distribution Agreement with Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus
Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals
AnaSpec Introduces Sixteen New Catalog Peptides
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine... - December 20, 2007 - AnaSpec, EGT Group
AnaSpec Introduces First Colorimetric SensoLyte™ MMP Assay Kit
AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Selection of Dye-Labeled Beta-Amyloid Peptides
AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 10 New Catalog Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2... - December 15, 2007 - AnaSpec, EGT Group
AnaSpec Releases New Antibodies Brochure
With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented... - December 14, 2007 - AnaSpec, EGT Group
Cardiovascular Sciences, Inc. Announces Funding Event
Cardiovascular Sciences, Inc. (CVSC), a corporation under the laws of Nevada, is excited to reveal an initial funding event with Seven Palm Investments, LLC of Illinois. After a recent assessment and restructuring of the company’s equity, the company and its investors are ready to move ahead... - December 12, 2007 - Cardiovascular Sciences, Inc.
AnaSpec Introduces Eight New Catalog Peptides and One Unusual Amino Acid
This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 17 New Anti-Tau Antibodies
Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) -... - December 06, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Collection of Bcl Peptides
AnaSpec introduced a collection of peptides related to the family of proteins called Bcl-2 (B-cell lymphoma 2) for use in cancer research or cell cycle research. - December 06, 2007 - AnaSpec, EGT Group
AnaSpec Celebrates the Holidays with Its Customers
AnaSpec will be adding a one pound box of See’s Candy into every order placed from now through the end of the year. - November 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces AnaTagTM Protein Labeling Kits with HiLytePlusTM
AnaSpec introduced a new series of AnaTagTM Labeling Kits now available with the revolutionary new HiLytePlus™ series of long-wavelength dyes. - November 29, 2007 - AnaSpec, EGT Group
Samaritan Presented Favorable Caprospinol Data at Alzheimer's Drug Development Summit
In an in vivo 'Proof of Concept' study, Samaritan Pharmaceuticals, Inc. has confirmed Caprospinol's (SP-233) efficacy in its ability to dramatically decrease beta amyloid plaque in the brain, accompanied by a complete recovery of memory back to baseline (p=0.002), as shown in a Morris water maze task. This study confirms previously reported in vitro data and suggests Caprospinol may not only slow the progress of Alzheimer's, but may also reverse plaque-related brain injuries associated with AD. - November 27, 2007 - Samaritan Pharmaceuticals
AnaSpec Introduces HiLytePlus™ Labeled Secondary Antibodies & Streptavidin
AnaSpec introduces a new collection of secondary antibodies and streptavidin labeled with the new HiLytePlus™ series of fluorescent dyes. - November 17, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Thirteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death... - November 11, 2007 - AnaSpec, EGT Group
AnaSpec Introduces HiLytePlus™ – AnaSpec’s Highest Performance Fluorescent Dyes
This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec’s HiLyte Fluor™ line, this series represents the next generation in AnaSpec’s line of high performance fluorescent dyes. With excitation... - November 09, 2007 - AnaSpec, EGT Group
Xcelience’s Scientific Director Selected to Lead Key Sessions on Upcoming Conferences
Dr. Steve Bannister’s expertise requested for several speaking engagements over the next year - October 31, 2007 - Xcelience, LLC
NCSRT Introduces WORKS™, an Integrated Program of Products, Applications Guides, Optimization Tools, and Services
NCSRT Introduces WORKS™, an integrated program of products, applications guides, optimization tools, and services to dramatically improve downstream processing in the biopharmaceutical production environment. With the patented SmartFlow™ TFF modules and industry leading PUROSEP®... - October 30, 2007 - NCSRT, Inc.
AnaSpec Introduces Anti-Keratin-18 & 19 Antibodies
AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the... - October 24, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Labeled RGD Peptide for In Vivo Imaging
Leveraging its dual expertise in peptides and detection reagents, AnaSpec has released c[RGDyK(HiLyte FluorTM 750)], a labeled RGD peptide that has produced significant imaging results in a recent in vivo research study. Extracellular matrix proteins containing the Arg-Gly-Asp (RGD) motif, and... - October 18, 2007 - AnaSpec, EGT Group
AnaSpec Introduces One New Amino Acid and Two New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced one new unusual amino acid and two new catalog peptides. HRP Prorenin; Decoy Handle Region Peptide- Cat# 62118 Sequence: RILLKKMPSV Fmoc-HomoArg(Pbf)-OH- Cat# 60004-1/ 60004-5 TP508;... - October 17, 2007 - AnaSpec, EGT Group
AnaSpec Launches New SensoLyteTM Caspase-8 Assay Kit
AnaSpec introduces its newest offering – the SensoLyte™ Homogeneous AFC Caspase-8 Assay Kit - October 11, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Improved Website Search Tool
AnaSpec has introduced Smart Search, an optimized site search engine for locating items in AnaSpec’s expansive collection of products. - October 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Anti-Keratin-18 & 19 Antibodies
AnaSpec has introduced two new catalog antibodies: Anti-Keratin-18 and Anti-Keratin-19. Intermediate filaments (IFs), together with actin microfilaments and tubulin microtubules, comprise the three major cytoskeletal networks that are found in most eukaryotic cells.1 Keratins, which are the... - October 06, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Fifteen New Catalog Peptides
AnaSpec introduced fifteen (15) new peptides for drug discovery research. - October 04, 2007 - AnaSpec, EGT Group
World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board
Samaritan announced today the appointment of James E.K. Hildreth, M.D., a world renowned physician and HIV researcher, to its Scientific Advisory Board. The work of Dr. Hildreth in HIV/AIDS dates back to 1986 and focuses on blocking HIV infection by learning how HIV gets into cells. He has published more than 80 scientific articles and holds six patents. - October 03, 2007 - Samaritan Pharmaceuticals
AnaSpec Has Introduced a Collection of Dye-Labeled Amino Acids and Resins
AnaSpec, one of the world’s leading providers of dye-labeled and FRET (fluorescent resonance energy transfer) peptides, has introduced a collection of dye-labeled amino acids and resins. Already conjugated with fluorescent dyes or quencher molecules, these ready-to-use building blocks... - September 27, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Nine New Catalog Peptides
AnaSpec introduced nine (9) new peptides for drug discovery research - September 26, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Nine New Catalog Antibodies
Continuing in its commitment to expand its antibody offerings, AnaSpec added nine (9) new antibodies to its growing collection of catalog antibodies. Anti-Estrogen Receptor-alpha (Paired 167) - Cat# 28002, 50 µg Host: rabbit polyclonal; Species Reactivity: human; monkey; chimpanzees;... - September 23, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Anti-LC Antibodies
AnaSpec has introduced its newest collection of Anti-LC antibodies that can be used as autophagosome markers. - September 21, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Thirty-Two New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-two (32) new peptides for drug discovery research. - September 16, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s First ACE2 Activity Assay Kit
With its reported relation to cardiovascular disease, kidney disease, and severe acute respiratory syndrome (SARS), Angiotensin I converting enzyme 2 (ACE2) has become an increasingly important therapeutic target. - September 12, 2007 - AnaSpec, EGT Group
AnaSpec Introduces New Kinase Peptide Library
AnaSpec, the key supplier of kinase peptide libraries mentioned in the articles, has announced the worldwide commercial availability of its newest kinase peptide library. - September 07, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Fifty-Five New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fifty-five (55) new peptides for drug discovery research. - September 05, 2007 - AnaSpec, EGT Group
New Labeled Antibodies: Anti-CD-3ε, Anti-CD79α
Leveraging its expertise in both detection reagents and antibodies, AnaSpec has introduced a new series of labeled Anti-CD-3ε and anti-CD79α antibodies. - August 29, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Thirty-Six New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirty-six (36) new peptides for drug discovery research. Protease-Activated Receptor-4; PAR-4 Agonist; amide; human Amyloid Precursor Protein (APP) (667-676); Swedish mutation Colivelin AGA-(C8R)... - August 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Industry’s Longest Wavelength Assay Kit for TACE Detection
This week AnaSpec introduced the SensoLyteTM 520 TACE Assay Kit, offering fluorescence detection at the industry’s longest wavelengths. With higher fluorescence quantum yield and longer emission wavelength, this kit shows less autofluorescence interference from test compounds and cellular... - August 28, 2007 - AnaSpec, EGT Group
AnaSpec’s Published References Passes 500
As compiled by Stanford University’s Highwire Press, the number of published papers that cite AnaSpec’s products has passed 500. - August 26, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 10 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added ten (10) new antibodies to its growing collection of catalog antibodies. Anti-MAP1-LC3 beta (NT) - Cat# 29783, 50 µg Host:rabbit polyclonal; Species... - August 25, 2007 - AnaSpec, EGT Group
AnaSpec Introduces CEF Control Peptide Pool
One of the world’s largest providers of catalog peptides, AnaSpec introduced its CEF Control Peptide Pool. Previously available only individually, this group of peptides is now available pooled. The CEF Control Peptide Pool is a group of 32 peptides, 8-12 amino acids in length, with... - August 23, 2007 - AnaSpec, EGT Group
AnaSpec Introduces 28 New Catalog Antibodies
Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a leading provider of integrated proteomics solutions, added twenty-eight (28) new antibodies to its growing collection of catalog antibodies. - August 22, 2007 - AnaSpec, EGT Group
Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve on Chemotherapy
Samaritan announced that it has entered into an exclusive licensing agreement with Georgetown University for a patent covering the Peripheral Benzodiazepine Receptor (PBR) which has led to Cancer drug candidates with the ability to inhibit cancerous tumors; and an imaging technique that could possibly distinguish cancerous tumors for a more targeted and improved chemotherapy. - August 21, 2007 - Samaritan Pharmaceuticals
AnaSpec Introduces New 2007-2009 Combinatorial Chemistry Catalog
One of the world’s largest providers of unusual amino acids, today AnaSpec announced the release of its 2007-2009 Combinatorial Chemistry catalog. - August 18, 2007 - AnaSpec, EGT Group
Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline
Samaritan Pharmaceuticals has exclusively licensed a patent application entitled "Structure Based Drug Design of Steroid Inhibitors" from Georgetown University. - August 16, 2007 - Samaritan Pharmaceuticals
Analytical Results Highlight Efficacy of AnaSpec MOG Peptides
Reporting on results gathered from its antibody and assay kit departments, AnaSpec has released data that supports the efficacy of its MOG(35-55) peptide. Analytical results reported the following: AnaSpec’s mouse/rat MOG(35-55) peptide induced EAE in C57BL/6 mice with 100% incident (10/10). - July 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Acetylated and Methylated Lysines
AnaSpec has introduced acetylated, mono-methylated, di-methylated and tri-methylated Lysine for the synthesis of histone peptides. The use of these building blocks, although not limited to making synthetic histone peptides, provides additional tools for researchers to help unravel the... - July 28, 2007 - AnaSpec, EGT Group
AnaSpec Introduces Fourteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced fourteen (14) new peptides for drug discovery research. HIV Nef (68–76) - Cat# 61673 This HIV nef peptide 68 to 76 amino acids was identified in HIV-infected individuals. It is a B7... - July 27, 2007 - AnaSpec, EGT Group